CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...